摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cu(α-aminoisobutyrato)2 | 15716-84-4

中文名称
——
中文别名
——
英文名称
Cu(α-aminoisobutyrato)2
英文别名
trans-bis(α-aminoisobutyrato)copper(II);bis(α-aminoisobutyrato)copper(II)
Cu(α-aminoisobutyrato)2化学式
CAS
15716-84-4;1181844-87-0;28143-35-3
化学式
C8H16CuN2O4
mdl
——
分子量
267.772
InChiKey
RISGPONJZRZXCY-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Novel trigonal-bipyramidal copper(II) complexes containing one discrete amino acid chelate: crystal structures of [Cu(L-val)(pmdt)]ClO4 and [Cu(aiba) (pmdt)]ClO4·H2O(L-val = L-valinate ion, aiba = α-aminoisobutyrate ion, and pmdt = N,N,N′,N″,N″-pentamethyldiethylenetriamine)
    摘要:
    The title mixed-ligand copper(II) complexes were characterized by X-ray crystallography. These complexes take on a trans (O-amino acid, N-central of pmdt) form, and their CuN4O core geometries are approximately regular trigonal bipyramidal, which is novel for copper(II) complexes containing a discrete amino acid chelate ring. (C) 1998 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0020-1693(97)06090-8
  • 作为产物:
    描述:
    以 neat (no solvent) 为溶剂, 生成 Cu(α-aminoisobutyrato)2
    参考文献:
    名称:
    Abderhalden, E.; Schnitzler, E., Zeitschrift fur Physiologische Chemie, 1927, vol. 163, p. 94 - 119
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: Cu: MVol.B4, 95, page 1644 - 1646
    作者:
    DOI:——
    日期:——
  • Structural and magnetic properties of a copper–amino acid salt: Copper (II) bis (α‐amino isobutyrato)
    作者:R. Calvo、M. A. Mesa、G. Oliva、J. Zukerman‐Schpector、O. R. Nascimento、M. Tovar、R. Arce
    DOI:10.1063/1.447389
    日期:1984.11.15
    The copper salt of the amino acid α-amino isobutyric acid was synthesized and the crystal structure was determined by x-ray techniques. The crystals are monoclinic, space group P21/c (Z=2) with a=10.470(3) Å, b=5.335(1) Å, c=10.201(3) Å, and β=115.6(2)°. The magnetic susceptibility, measured between 1.4 and 12 K, shows a Curie–Weiss behavior with antiferromagnetic Curie temperature Tc =0.66 K. These data and a simple mean field argument which assumes equal superexchange pathways between Cu nearest neighbors gives J≂0.22 K (antiferromagnetic) for the exchange coupling constant between copper ions. The gyromagnetic factor g and the linewidth ΔH of the single exchange narrowed EPR line were measured as a function of the orientation of the applied magnetic field at room temperature. The gyromagnetic tensor reflects the molecular properties of the square planar Cu(II) complex and the orientation of these molecules within the unit cell of the crystal. The observed magnitude and angles variation of ΔH is analyzed in terms of the exchange narrowed dipolar and hyperfine linewidth. An estimate of the exchange coupling constant from the observed narrowing of the hyperfine broadening support the value obtained from the susceptibility data. Since the exchange parameter J obtained by assuming exchange narrowing of the dipolar linewidth is three times smaller than that obtained from the susceptibility data, we suggest the possibility of a quasi-two-dimensional magnetic behavior, which is supported by our crystallographic data.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-3-BOC-5-甲基-1,2,3-氧杂噻唑烷-2,2-二氧化物 (R)-2-苯基-3-羟基丙酸 (R)-2-羟基-2-(2-(2-(2-甲氧基-5-甲基吡啶-3-基)乙基)-琥珀酸 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4S)-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S)-4-i-丙基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (4R)-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S,3R)-2,3-二羟基-3-(2-吡啶基)丙酸乙酯,N-氧化物 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (2-三甲基甲硅烷基)-乙氧基甲基三氟硼酸钾 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 (11bR,11''bR)-2,2''-[氧双(亚甲基)]双[4-羟基-4,4''-二氧化物-二萘并[2,1-d:1'',2''-f][1,3,2]二氧磷杂七环 (11aR)-10,11,12,13-四氢-5-羟基-3,7-二-1-萘-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂磷杂八环 (1-氨基丁基)磷酸 (-)-N-[(2S,3R)-3-氨基-2-羟基-4-苯基丁酰基]-L-亮氨酸甲酯 齐特巴坦